
DBV Technologies SA
DBVTHealthcare|Biotechnology|France
$16.49
+0.41 (+2.55%)
Tangible Book
$3.53
Earnings Power
$2.43
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
7.62,
184.04,
486.83
],
"ebit_estimate": [
-150.78,
10.36,
273.94
],
"ebitda_estimate": [
-150.38,
5.99,
274.93
],
"net_income_estimate": [
-149.7,
11.37,
263.91
],
"per_share_eps_estimate": [
-1.97,
-0.86,
1.26
],
"eps_nri_estimate": [
-2.27,
-0.81,
0.83
],
"dividend_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
1.37,
0.61,
1.97
],
"pretax_income_estimate": [
-136.64,
-53.85,
67.4
],
"operating_cash_flow_per_share_estimate": [
-1.92,
-1.16,
0.35
],
"roa_estimate": [
null,
null,
null
],
"roe_estimate": [
-88.5,
-87.2,
100.1
],
"gross_margin_estimate": [
100,
96.4,
96.3
],
"operating_cash_flow_estimate": [
-164.52,
-99.58,
30.31
],
"pettm_estimate": [
0,
0,
13.05
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "422.18",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 422.18,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": 54.68,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612"
],
"revenue_estimate": [
1.41,
1.41,
1.41
],
"ebit_estimate": [
-42.95,
-40.76,
-35.86
],
"ebitda_estimate": [
-42.24,
-40.05,
-35.15
],
"net_income_estimate": [
null,
null,
null
],
"per_share_eps_estimate": [
null,
null,
null
],
"eps_nri_estimate": [
-0.51,
-0.46,
-0.4
],
"dividend_estimate": [
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null
],
"pretax_income_estimate": [
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null
],
"roa_estimate": [
null,
null,
null
],
"roe_estimate": [
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null
],
"pettm_estimate": [
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "422.18",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 422.18,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": 54.68,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}